Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vimovo
Pharma
Grünenthal buys up Nebido from Bayer for $500 million
Bayer has found a buyer for its hypogonadism drug Nebido but is keeping it in Germany as Grünenthal picks up its global rights for 500 million euros.
Kevin Dunleavy
Jul 14, 2022 9:44am
AstraZeneca's rummage sale continues with second deal in a week
Nov 6, 2018 10:08am
AstraZeneca gins up $815M in rights deal for Nexium, Vimovo
Oct 30, 2018 12:00pm
Horizon's controversial combo Vimovo gets a higher price—again
Feb 15, 2018 11:16am
Horizon meds and specialty pharmacies face new questions
Dec 8, 2017 11:34am
Payers, patients target pricey meds that combo cheap generics
Oct 31, 2016 11:15am
